Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03707925 · ClinicalTrials.gov registry record · NA
Bronchoscopic Laser Ablation of Peripheral Lung Tumors
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03707925: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT03707925 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03707925, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
As our population ages and we diagnose early lung cancer in patients who cannot undergo surgery due to multiple medical conditions, there is growing interest in minimally invasive modalities to treat these tumors. In this study we are assessing the ability of bronchoscopic laser ablation to kill the cancer cells in these tumors. Patients will undergo bronchoscopy (a tube-like instrument inserted through the mouth to view the inside of the trachea, air passages, and lungs). A thin catheter will be passed through the wind-pipes and into the lung tumor with computed tomography guidance. A laser probe is then passed through this catheter and it is used to destroy the tumor with heat. Patients will then undergo lung surgery with resection of the tumor, and the resected specimen will be reviewed to describe the amount of tumor-kill produced by the laser.
Interventions
- PROCEDURE Cone-Beam Computed Tomography
- PROCEDURE Conventional Surgery
- PROCEDURE Laser Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-09-18 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03707925
The ClinicalTrials.gov registry entry for NCT03707925 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cone-Beam Computed Tomography is the first listed.
NCT03707925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03707925 about?
NCT03707925 is a clinical study titled "Bronchoscopic Laser Ablation of Peripheral Lung Tumors". As our population ages and we diagnose early lung cancer in patients who cannot undergo surgery due to multiple medical conditions, there is growing interest in minimally invasive modalities to treat these tumors. In this study we are assessing the ability of bronchoscopic laser ablation to kill the...
What is the current status of trial NCT03707925?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-09-18. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT03707925?
The interventions under investigation include: Cone-Beam Computed Tomography (PROCEDURE), Conventional Surgery (PROCEDURE), Laser Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT03707925?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.